OCT 11, 2016 5:24 AM PDT

Advertising Psychiatric Medication: Does It Help?

In most countries, it’s illegal to advertise prescription drugs directly to consumers. No slick magazine adverts and no television commercials. Ad for prescription drugs are just not part of the landscape in other countries. In the United States, the rules for drug ads were relaxed in 1997 and since then it’s not at all uncommon to see an ad for arthritis medication during a sporting event and ads for menopausal drugs during a Lifetime movie of the week. The marketing of prescription drugs is big business.
 Advertising medication increases prescriptions, but is that always good?
Studies do show that if a patient has seen ad ad for medication they are much more likely to ask for it at the doctor, and they usually get it. A new study out of Brown University examined the effect of advertising psychiatric medications has had on mental health. There’s not a lot of data and the question covers a broad range of information, but the authors stated that looking at the trends was important.   
 
Sara Becker, a research assistant professor at the Brown University School of Public Health and the Warren Alpert Medical School  and the lead author in the study said, “On a basic level, the goal of our review was to begin addressing an important and rarely examined public health question. Is this enormous multibillion dollar industry of direct-to-consumer advertising of psychiatric medication affecting public health in a positive or negative way? There are many possible ways to answer this question — we began by taking a close look at patient and physician behavior in response to these ads.”
 
Focusing on the marketing and prescribing of psychiatric medicines was a good place to start, since those mediations make up a huge chunk of direct to consumer ads for prescription drugs, and they are some of the biggest sellers. Is it because of the ads? Is the state of public health been improved by these ads? That’s what the team from Brown felt was an important question raise.
 
Finding the data that could answer this question was a tough task. Direct-to-consumer advertising (DTCA) has been around for a while, but there’s almost no research on how or if it impacts a patient/doctor conversation. While there were some studies, almost none of them focused on psychiatric medications, despite how many of them are heavily advertised and sold. The Brown study was only able to review four research studies that met all of their criteria. They wanted to look at studies that included psychiatric medications that had been advertised, that included data on prescribing information sorted by patient requests for those drugs and that also had information on the doctor/patient interaction at the point where care was being given (as opposed to asking doctors or patients to recall visits that had already happened)
 
In one study analyzed, researchers used paid actors to go to a doctor and describe symptoms of general depression. Some actors asked for a specific medication that had been advertised, some asked in general for medication, without naming any certain drug and some did not ask at all. The results showed patients were more likely to be prescribed a medication when asking for it by name, than not. The other studies reviewed by the Brown team were similar, and one compared prescribing rates in the US to those in Canada, where DTCA is illegal.
 
The issue the team noticed in all the studies that regardless of whether a patient exhibited signs of severe illness or just transient symptoms, the act of asking for a medication is likely to result in a prescription regardless of the severity of the symptoms, and this could lead to over-prescribing in some patients.  While more information is always good for patients to have, and perhaps some of these ads have led those who need treatment to seek it, the flip side is the danger of over-prescribing. Dr. Becker summarized the study results when she said,
“The most important conclusion of our study is that more research is needed.”
 
The National Institute on Drug Abuse funded the study and it was published in the journal Clinical Psychiatry. Check out the video to learn more about the effect ads have on medical treatment.

Sources: Journal of Clinical Psychiatry, UPI, Brown University, Mad In America 
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 19, 2020
Drug Discovery & Development
Synapse-Saving Proteins Could Stave Off Alzheimer's
JUL 19, 2020
Synapse-Saving Proteins Could Stave Off Alzheimer's
Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the stru ...
AUG 10, 2020
Cannabis Sciences
Cannabis Use During Pregnancy Linked to Autism
AUG 10, 2020
Cannabis Use During Pregnancy Linked to Autism
Researchers from The Ottawa Hospital in Ontario, Canada, have found that children born to mothers who used cannabis whil ...
AUG 16, 2020
Cell & Molecular Biology
The Cerebellum Is Far Bigger Than We Thought
AUG 16, 2020
The Cerebellum Is Far Bigger Than We Thought
Researchers are revealing more about the critical functios of the cerebellum, which is Latin for "little brain."
AUG 25, 2020
Neuroscience
Dementia Kills Almost 3 Times More than Previously Thought
AUG 25, 2020
Dementia Kills Almost 3 Times More than Previously Thought
Researchers have found that around 13.6% of deaths in the U.S. may come as the result of dementia. The figure, they say, ...
SEP 11, 2020
Neuroscience
Children Use Both Sides of Brain for Language, Unlike Adults
SEP 11, 2020
Children Use Both Sides of Brain for Language, Unlike Adults
Researchers from Georgetown University medical center have found that young children use both the right and left sides o ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
Loading Comments...